Natural products targeting mitochondria: emerging therapeutics for age-associated neurological disorders
- 20 November 2020
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 221, 107749
Abstract
No abstract availableKeywords
Funding Information
- Glenn Foundation for Medical Research
- National Institute on Aging
- National Institute of Allergy and Infectious Diseases
This publication has 263 references indexed in Scilit:
- The Hallmarks of AgingCell, 2013
- Mitochondrial Dynamics Associated with Oxygen-Glucose Deprivation in Rat Primary Neuronal CulturesPLOS ONE, 2013
- Epigallocatechin-3-gallate prevents oxidative phosphorylation deficit and promotes mitochondrial biogenesis in human cells from subjects with Down's syndromeBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Shaping the role of mitochondria in the pathogenesis of Huntington's diseaseThe EMBO Journal, 2012
- Chemical Modification of the Multitarget Neuroprotective Compound FisetinJournal of Medicinal Chemistry, 2011
- First-Pass Metabolism via UDP-Glucuronosyltransferase: a Barrier to Oral Bioavailability of PhenolicsJournal of Pharmaceutical Sciences, 2011
- Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's diseaseThe Lancet Neurology, 2011
- Astaxanthin protects against MPTP/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitroFood and Chemical Toxicology, 2011
- Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuliEMBO Molecular Medicine, 2010